large neuromedin N



large neuromedin N

S1SS1D2DD2S3SS3E4EE4E5EE5E6EE6M7MM7K8KK8A9AA9L10LL10E11EE11A12AA12D13DD13F14FF14L15LL15T16TT16N17NN17M18MM18H19HH19T20TT20S21SS21K22KK22I23II23S24SS24K25KK25A26AA26H27HH27V28VV28P29PP29S30SS30W31WW31K32KK32M33MM33T34TT34L35LL35L36LL36N37NN37V38VV38C39CC39S40SS40L41LL41V42VV42N43NN43N44NN44L45LL45N46NN46S47SS47... and 78 more residue(s)...... and 78 more residue(s)

SMILES None
InChIKey None
Sequence SDSEEEMKALEADFLTNMHTSKISKAHVPSWKMTLLNVCSLVNNLNSPAEETGEVHEEELVARRKLPTALDGFSLEAMLTIYQLHKICHSRAFQHWELIQEDILDTGNDKNGKEEVIKRKIPYIL

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

large neuromedin N

S1SS1D2DD2S3SS3E4EE4E5EE5E6EE6M7MM7K8KK8A9AA9L10LL10E11EE11A12AA12D13DD13F14FF14L15LL15T16TT16N17NN17M18MM18H19HH19T20TT20S21SS21K22KK22I23II23S24SS24K25KK25A26AA26H27HH27V28VV28P29PP29S30SS30W31WW31K32KK32M33MM33T34TT34L35LL35L36LL36N37NN37V38VV38C39CC39S40SS40L41LL41V42VV42N43NN43N44NN44L45LL45N46NN46S47SS47... and 78 more residue(s)...... and 78 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.